236 related articles for article (PubMed ID: 23543084)
1. XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: a meta-analysis.
Li S; Deng Y; You JP; Chen ZP; Peng QL; Huang XM; Lu QH; Huang XL; Zhao JM; Qin X
Dig Dis Sci; 2013 Jul; 58(7):1880-90. PubMed ID: 23543084
[TBL] [Abstract][Full Text] [Related]
2. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
[TBL] [Abstract][Full Text] [Related]
3. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
Li Y; Liu F; Tan SQ; Wang Y; Li SW
PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511
[TBL] [Abstract][Full Text] [Related]
4. XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: A meta-analysis of case-control studies.
Dai L; Wang K; Zhang J; Lv Q; Wu X; Wang Y
Int J Cancer; 2009 Sep; 125(5):1102-9. PubMed ID: 19444915
[TBL] [Abstract][Full Text] [Related]
5. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
[TBL] [Abstract][Full Text] [Related]
6. XRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision.
Zhao DY; Cheng L; Yu J; Shen H
Cancer Biomark; 2014; 14(6):449-56. PubMed ID: 25335737
[TBL] [Abstract][Full Text] [Related]
7. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta-analysis.
Du Y; Han LY; Li DD; Liu H; Gao YH; Sun DJ
Asian Pac J Cancer Prev; 2013; 14(9):5483-7. PubMed ID: 24175846
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of XRCC1 single nucleotide polymorphism and susceptibility to gynecological malignancies.
Zhang XQ; Li L
Medicine (Baltimore); 2021 Dec; 100(50):e28030. PubMed ID: 34918657
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis demonstrates association of XRCC1 genetic polymorphism Arg399Gln with esophageal cancer risk in the Chinese population.
Zhang ZY; Xuan Y; Jin XY; Tian X; Wu R
Genet Mol Res; 2013 Jan; 12(3):2567-77. PubMed ID: 23359058
[TBL] [Abstract][Full Text] [Related]
10. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
[TBL] [Abstract][Full Text] [Related]
11. Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population.
Kumar A; Pant MC; Singh HS; Khandelwal S
Mutat Res; 2012 Jan; 729(1-2):24-34. PubMed ID: 21945240
[TBL] [Abstract][Full Text] [Related]
12. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
13. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.
Ma WQ; Han XQ; Wang X; Wang Y; Zhu Y; Liu NF
PLoS One; 2016; 11(11):e0166961. PubMed ID: 27870881
[TBL] [Abstract][Full Text] [Related]
14. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.
Zhang H; Liu H; Knauss JL
Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population.
Xing D; Qi J; Miao X; Lu W; Tan W; Lin D
Int J Cancer; 2002 Aug; 100(5):600-5. PubMed ID: 12124811
[TBL] [Abstract][Full Text] [Related]
16. XRCC1 Arg194Trp and Arg280His polymorphisms increase bladder cancer risk in Asian population: evidence from a meta-analysis.
Fang Z; Chen F; Wang X; Yi S; Chen W; Ye G
PLoS One; 2013; 8(5):e64001. PubMed ID: 23704969
[TBL] [Abstract][Full Text] [Related]
17. XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis.
He LW; Shi R; Jiang L; Zeng Y; Ma WL; Zhou JY
PLoS One; 2014; 9(11):e111981. PubMed ID: 25375625
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of associations between XRCC1 gene polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis.
Zhang MY; Yang XK; Lv TT; Wu J; Xu SZ; Wang JB; Pan HF; Ye DQ
Int J Rheum Dis; 2018 Jan; 21(1):179-185. PubMed ID: 28198159
[TBL] [Abstract][Full Text] [Related]
19. Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: A meta-analysis.
Gu X; Sun H; Chang L; Sun R; Yang H; Zhang X; Cong X
Neural Regen Res; 2013 Sep; 8(26):2468-77. PubMed ID: 25206557
[TBL] [Abstract][Full Text] [Related]
20. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Classen V; Bernges U; Philipp M
Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
